Copyright
©The Author(s) 2023.
World J Hepatol. Mar 27, 2023; 15(3): 386-392
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.386
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.386
Figure 1 Diagram shows the correlation between nonalcoholic fatty liver disease and engineered exosome.
MVB: Multivesicular body; EV: Extracellular vesicles; NASH: Nonalcoholic steatohepatitis; NAFL: Nonalcoholic fatty liver; STAT3: Signal transducer and activator of transcription 3; RISC: RNA-induced silencing complex; MST1: Mammalian STE20-like kinase 1; USP7: Ubiquitin specific peptidase 7; KLF3: Kruppel-like factor 3; PINK: PETN induced kinase 1; PI3K: Phosphatidylinositol-4,5-Bisphosphate 3-Kinase; Akt: Protein kinase B.
- Citation: Ding J, Xu C, Xu M, He XY, Li WN, He F. Emerging role of engineered exosomes in nonalcoholic fatty liver disease. World J Hepatol 2023; 15(3): 386-392
- URL: https://www.wjgnet.com/1948-5182/full/v15/i3/386.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i3.386